As of April 18, 2025, Voyager Therapeutics (VYGR) has a market cap of $0.17 billion USD. According to our data, Voyager Therapeutics is ranked No.7122 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 18, 2025 | $0.17 B |
-43.68%
|
Dec 31, 2024 | $0.31 B |
-32.82%
|
Dec 29, 2023 | $0.46 B |
38.36%
|
Dec 30, 2022 | $0.33 B |
125.09%
|
Dec 31, 2021 | $0.15 B |
-62.10%
|
Dec 31, 2020 | $0.39 B |
-48.75%
|
Dec 31, 2019 | $0.76 B |
48.40%
|
Dec 31, 2018 | $0.51 B |
-43.37%
|
Dec 29, 2017 | $0.91 B |
30.30%
|
Dec 30, 2016 | $0.70 B |
-41.83%
|
Dec 31, 2015 | $1.20 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Biogen
BIIB
|
$17.36 B |
-0.001 M
|
![]() USA
|
![]() bluebird bio
BLUE
|
$40.53 M |
0.000 M
|
![]() USA
|
![]() Sarepta Therapeutics
SRPT
|
$5.22 B |
0.000 M
|
![]() USA
|
![]() REGENXBIO
RGNX
|
$0.30 B |
0.000 M
|
![]() USA
|
![]() uniQure
QURE
|
$0.70 B |
-0.000 M
|
![]() Netherlands
|
![]() Editas Medicine
EDIT
|
$0.11 B |
-0.000 M
|
![]() USA
|
![]() CRISPR Therapeutics
CRSP
|
$3.26 B |
0.000 M
|
![]() Switzerland
|
![]() Intellia Therapeutics
NTLA
|
$0.75 B |
-0.000 M
|
![]() USA
|
![]() Sangamo Therapeutics
SGMO
|
$0.16 B |
-0.989 M
|
![]() USA
|
![]() Adverum Biotechnologies
ADVM
|
$61.21 M |
0.000 M
|
![]() USA
|
![]() Solid Biosciences
SLDB
|
$0.20 B |
0.000 M
|
![]() USA
|
![]() MeiraGTx
MGTX
|
$0.43 B |
-0.000 M
|
![]() USA
|
![]() Rocket Pharmaceuticals
RCKT
|
$0.67 B |
-0.000 M
|
![]() USA
|
![]() Passage Bio
PASG
|
$20.51 M |
0.000 M
|
![]() USA
|
Market Cap | = | VYGR Stock Price | * | VYGR Shares Outstanding |
= | $3.16 | * | 55.21 M | |
= | $0.17 B |